Alper Yavas, MSc.

Alper Yavas is a PhD student in the DMD Genetic Therapy Group since May 2019.

His research focuses on the regulation of IGF-1 signaling to increase muscle regeneration and growth in DMD, using antisense oligonucleotides for the downregulation of IGF-binding proteins, the modulation of Igf-1 alternative splicing and the redirection of Igf-1 alternative polyadenylation.